| Dr Marcus Christian Ravnan, PHARMD | |
|
7373 West Ln, Stockton, CA 95210-3377 | |
| (209) 476-5478 | |
| (209) 476-3306 |
| Full Name | Dr Marcus Christian Ravnan |
|---|---|
| Gender | Male |
| Speciality | Pharmacist |
| Location | 7373 West Ln, Stockton, California |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1407020738 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 183500000X | Pharmacist | RPH47450 (California) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Dr Marcus Christian Ravnan, PHARMD 7373 West Ln, Stockton, CA 95210-3377 Ph: (209) 476-5478 | Dr Marcus Christian Ravnan, PHARMD 7373 West Ln, Stockton, CA 95210-3377 Ph: (209) 476-5478 |
News Archive
Cystic fibrosis is the most common fatal genetic disease affecting Canadian children and young adults, more than two children each and every week are diagnosed with cystic fibrosis (CF). New research at Ryerson University, in partnership with The Hospital for Sick Children, is examining the interaction between lab-tested drugs and the defective protein that causes CF to understand how and why the drugs work and to create stronger, more powerful second generation drugs to treat CF.
An estimated 2.5 million Americans suffer from irregular heartbeats-also known as atrial fibrillation. Baylor Health Care System is raising awareness about this often misunderstood, but potentially life changing cardiovascular condition whose incidence is on the rise and expected to more than double by 2050.
Highly active antiretroviral therapy has increased the longevity and quality of life for people living with human immunodeficiency virus. But it requires strict adherence in taking the medicine, something that is extremely difficult for many individuals to do.
Boehringer Ingelheim and Eli Lilly and Company today announced that they have received a positive opinion from the European Medicines Agency's medicinal committee recommending approval of Jentadueto,which combines the DPP-4 inhibitor, linagliptin and metformin in a single tablet. If approved by the European Commission, linagliptin/metformin hydrochloride (HCl) will provide a new, single-tablet treatment option, taken twice-daily, for adults with Type 2 Diabetes who need to improve control of their blood glucose.
› Verified 7 days ago
Penny Gibbons Burke, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1212 N California St, Stockton, CA 95202 Phone: 209-468-8711 Fax: 209-468-8712 | |
Dr. Ree Tran, PHARM.D. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1050 N Wilson Way, Stockton, CA 95205 Phone: 209-948-0950 | |
Linh N Dang, PHARM D Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1528 E Fremont St, Stockton, CA 95205 Phone: 209-467-7861 | |
Lalitkumar Sukhram Singh Rajora, PHARMD, MS Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1801 E March Ln Ste B270, Stockton, CA 95210 Phone: 650-935-1275 | |
Dr. David C Norris, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 6455 Pacific Ave, Stockton, CA 95207 Phone: 209-478-5062 | |
Joan Y Chang, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1050 N Wilson Way, Stockton, CA 95205 Phone: 209-948-0950 | |
An Nguyen, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 7850 West Ln, Stockton, CA 95210 Phone: 209-475-9515 Fax: 209-473-9521 |